RCUS

15.6480.84%
TJ

Terry J. Rosen

Lead Independent Director

Dr. Terry J. Rosen, Ph.D., is Vice Chair of The Salk Institute For Biological STUDIES, San Diego, California. Dr. Rosen serves as Director at PACT Pharma, Inc. and Epiodyne, Inc. He co-founded Arcus Biosciences, Inc. in 2015 and has been its Chief Executive Officer since May 2015. Dr. Rosen has been the Chairman of Arcus Biosciences, Inc since December 2017 and its Director since April 2015. He serves as a Board Member of Sonoma Biotherapeutics, Inc. He also served as the Chief Executive Officer of PACT Pharma, Inc. (PACT Pharma), a biopharmaceutical company, from November 2016 to December 2017. Dr. Rosen served briefly in April 2015 as the Chief Executive Officer of FLX Bio, Inc., (FLX Bio), a biopharmaceutical company that was spun-off by Flexus Biosciences, Inc., a biopharmaceutical company. Previously, Dr. Rosen co-founded (with Dr. Jaen) and served as the Chief Executive Officer of Flexus Biosciences, Inc. from October 2013 to April 2015, when it was acquired by Bristol-Myers Squibb. Prior to that, he was at Amgen, Inc. (Amgen), a biopharmaceutical company, from August 2004 to January 2013 where he served as Vice President of Therapeutic Discovery from November 2011 to January 2013. He also worked at Tularik Inc., a biopharmaceutical company, from October 1993 to August 2004 when it was acquired by Amgen, Pfizer Central Research, a biopharmaceutical company, from December 1987 to September 1993 and Abbott Laboratories, a health care company, from July 1985 to December 1987. He was Vice President of Research at Cytokinetics, Incorporated. He was Executive Vice President - Operations at Tularik Inc. since January 2001. He was Chief Executive Officer at RAPT Therapeutics, Inc. Dr. Rosen serves on the Board of trustees of the Salk Institute, as well as on the Board of trustees of the California Life Sciences Association. He has been an Independent Director of Ideaya Biosciences, Inc. since January 2016 and served as its Independent Chairman of the Board since June 2023 until June 2026 and serves as its Lead Independent Director since June 2026. He is Director at PACT Pharma and TUSK Therapeutics Ltd. Dr. Rosen serves on the Board of trustees of the Berkeley Foundation. Dr. Rosen serves as Director of Simcha Therapeutics Holding Company, Limited Liability Company. Dr. Rosen also serves on the scientific advisory Board of Sirenas, Limited Liability Company, he holds a B.S. in Chemistry from the University of Michigan and a Ph.D. in Chemistry from the University of California, Berkeley.

Positions